Kezar Life Sciences to Participate in Upcoming Virtual Investor Conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, today announced members of the executive team will present during upcoming virtual investor conferences. The details of the presentations are as follows: Wells Fargo 2020 Virtual Biotech Conference Fireside Chat: Thursday, September 10, 2020, 1:20pm EDT Presenter

Click to view original post